14:00 – 14:15
Reimagining Oral Delivery of Peptide and Protein Drugs
1. Barriers to the oral administration of peptide & protein drugs
2. Development of self-emulsifying delivery systems for GLP1 analogues
3. Oral bioavailability of GLP-1 analogues: what is achievable?
2. Development of self-emulsifying delivery systems for GLP1 analogues
3. Oral bioavailability of GLP-1 analogues: what is achievable?
14:15 – 14:30
Non-Invasive Routes for Large Molecules
1. Understand the key challenges and physiological barriers associated with non-invasive delivery of large molecule therapeutics
2. Explore the design principles and material considerations behind engineering multifunctional carriers
3. Evaluate preclinical data demonstrating the pharmacokinetic, biodistribution, and therapeutic performance of these engineered carriers
2. Explore the design principles and material considerations behind engineering multifunctional carriers
3. Evaluate preclinical data demonstrating the pharmacokinetic, biodistribution, and therapeutic performance of these engineered carriers
14:30 – 14:45
Solving Formulation Challenges with Advanced Capsule Technologies - From Enteric Protection to Customized Capsule Solutions
14:45 – 15:00
Breaking the Barriers To Oral Delivery: What’s Next For Macromolecule Bioavailability?
• Current bottlenecks from the industry's point of view
• Oral bioavailability: What can be achieved? Can we go beyond?
• Bioavailability for macromolecules
• The pros & cons of available technologies for oral delivery of macromolecular drugs
• Oral bioavailability: What can be achieved? Can we go beyond?
• Bioavailability for macromolecules
• The pros & cons of available technologies for oral delivery of macromolecular drugs
15:00
End of R&D Spotlight
